AI驱动的化学品安全性评估:技术范式、应用进展与未来展望
AI-Driven Chemical Safety Assessment: Technical Paradigms, Application Progress and Future Prospects
人工智能(Artificial Intelligence, AI)技术的快速发展正在深刻重塑化学品安全性评估的传统模式。本文系统综述了 AI,尤其是机器学习和深度学习方法在计算毒理学领域的研究进展与应用现状。从数据基础、算法体系与模型可解释性这 3 个核心维度,梳理了 AI 驱动安全性评估技术范式的演进路径,并结合药物研发、化妆品安全性评估以及环境新污染物治理等典型应用场景,评述了相关技术从“替代实验手段”向“安全性赋能设计工具”的角色转变;在此基础上,文章进一步分析了国际监管框架对计算毒理学方法的接受与规范化进展,探讨了 AI 模型在可解释性、复杂体系评估、系统集成以及伦理与标准化等方面面临的关键挑战。总之,本文梳理了技术演进脉络,提出了智能毒理系统的概念框架,旨在为 AI 驱动化学品安全性评估技术的科学研究与监管应用提供系统参考与前瞻性思考。
The rapid development of artificial intelligence (AI) is profoundly reshaping the traditional paradigm of chemical safety assessment. This paper systematically reviews the research progress and application status of AI, particularly machine learning and deep learning methods, in the field of computational toxicology. From three core dimensions—data foundation, algorithm system and model interpretability, the evolutionary path of the AI-driven safety assessment technical paradigm is summarized. Combined with typical application scenarios such as drug research and development, cosmetic safety evaluation, and the control of emerging environmental pollutants, the role transformation of related technologies from "alternative experimental methods" to "safety-enabled design tools" is discussed. On this basis, the paper further analyzes the acceptance and standardization progress of computational toxicology methods in international regulatory frameworks, and explores the key challenges faced by AI models in terms of interpretability, complex system assessment, system integration, ethics, and standardization. In summary, this paper sorts out the context of technological evolution and proposes a conceptual framework for intelligent toxicology systems, aiming to provide a systematic reference and forward-looking perspective for the scientific research and regulatory application of AI-driven chemical safety assessment technologies.
| [1] |
WANG Z, WALKER G W, MUIR D C G, |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
ROSS J, BELGODERE B, CHENTHAMARAKSHAN V, |
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
European Parliament Council of the EU. Regulation (EC) No 1223/2009. on cosmetic products (recast) [R/OL].https://eur-lex.europa.eu/eli/reg/2009/1223/oj/eng. |
| [22] |
OECD. Guideline No. 497: Defined approaches on skin sensitisation [S/OL].https://www.oecd.org/en/publications/guideline-no-497-defined-approaches-on-skin-sensitisation_b92879a4-en.html. |
| [23] |
所雅琼, 罗飞亚, 张凤兰, |
| [24] |
|
| [25] |
|
| [26] |
施荣鑫, 张林, 曹泽星. 机器学习辅助预测潜在 A 类神经毒剂及其降解性质 [J].环境化学, 2025, 44(7):2727-2738. |
| [27] |
|
| [28] |
OECD. (Q)SAR Assessment framework: Guidance for the regulatory assessment of (Quantitative) structure activity relationship models, predictions, and results based on multiple predictions[R]. Paris: OECD Publishing,2023. |
| [29] |
ECHA. How to use read-across and (Q)SARs under REACH[R]. Helsinki: European Chemicals Agency,2022. |
| [30] |
U.S. Senate. S. 5002: FDA Modernization Act 2.0 (117 th Congress) [R/OL].https://www.congress.gov/bill/117th-congress/senate-bill/5002. |
| [31] |
中华人民共和国生态环境部. 新化学物质环境管理登记指南 [R].北京: 生态环境部, 2020. |
| [32] |
国家药品监督管理局. 国家药品监督管理局公告2021 年第 51 号: 化妆品安全评估技术导则(2021 年版)[EB/OL]. (2021-04-19). https://www.nmpa.gov.cn/xxgk/ggtg/hzhpggtg/jmhzhptg/20210419163037171.html. |
| [33] |
|
| [34] |
|
| [35] |
|
国家重点研发计划课题(2023YFF1204904)
海关总署科研项目(2024HK185)
/
| 〈 |
|
〉 |